Gene therapy for bladder cancer

World Journal of Urology

Volumn 18, Issue 2, 2000, Pages 148-151

  Pagliaro, Lance C ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS; BLADDER TUMOR; GENE THERAPY; GENE VECTOR; GENETICS; HUMAN; METHODOLOGY; REVIEW; TRANSITIONAL CELL CARCINOMA;

ADENOVIRIDAE; CARCINOMA, TRANSITIONAL CELL; GENE THERAPY; GENETIC VECTORS; HUMANS; URINARY BLADDER NEOPLASMS;

EID: 0034170763     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003450050188     Document Type: Article

References (23)

1. Bass C, Cabrera G, Elgavish A, Robert B, Siegal GP, Anderson SC, Maneval DC (1995) Recombinant adenovirus-mediated gene transfer to genitourinary epithelium in vitro and in vivo. Cancer Gene Ther 2: 97-104
2. dayman GL, El-Naggar AK, Lippman SM, Henderson YC, Frederick M, Merritt JA, Zumstein LA, Timmons TM, Liu TJ, Ginsberg L, Roth JA, Hong WK, Bruso P, Goepfert H (1998) Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinoma. J Clin Oncol 16: 2221-2232
3. Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen S-C, Nichols PW, Skinner DG, Jones PA, Cote RJ (1994) Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331: 1259-1264
4. Demers GW, Harris MP, Wen SF, Engler H, Nielsen LL, Maneval DC (1998) A recombinant adenoviral vector expressing full-length human retinoblastoma susceptibility gene inhibits human tumor cell growth. Cancer Gene Ther 5: 207-214
5. Droller MJ (1997) Clinical presentation, investigation, and staging of bladder cancer. In: Raghaven D, Scher HI, Leibel SA, Lange PH (eds) Principles and practice of genitourinary oncology. Lippincott-Raven, Philadelphia, pp 249-259
6. Gomez-Manzano C, Fueyo J, Kyritsis AP, McDonnell TJ, Steck PA, Levin VA, Yung WKA (1997) Characterization of p53 and p21 functional interactions in glioma cells en route to apoptosis. J Natl Cancer Inst 89: 1036-1044
7. Keyhani A, Liu B, Dinney CPN, Pagliaro LC (1999) p53 adenovirus-mediated gene transfer in bladder cancer (meeting abstract). Proc Annu Meet Am Assoc Cancer Res 40: A3477
8. Kirsch DG, Kastan MB (1998) Tumor-suppressor p53: implications for tumor development and prognosis. J Clin Oncol 9: 3158-3168
9. Li Y, Pong RC, Bergelson JM, Hall MC, Sagalowsky AI, Tseng CP, Wang Z, H sieh JT (1999) Loss of adenoviral receptor expression in human bladder cancer cells: a potential impact on the efficacy of gene therapy. Cancer Res 59: 325330
10. Liang C, Cheville JC, Neumann RM, Leibovich BC, Egan KS, Spotts BE, Bostwick DG (1999) Survival of patients with carcinoma in situ of the urinary bladder. Cancer 85: 2469-2474
11. Lowe SW, Ruley HE, Jacks T, Houseman DE (1993) p53dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
12. Morris BD, Drazan KE, Csete ME, Werthman PE, Van Bree MP, Rosenthal JT, Shaked A (1994) Adenoviral-mediated gene transfer to bladder in vivo. J Urol 152: 506-509
13. Pagliaro LC (1996) Retinoblastoma gene in malignancy. In: Freireich EJ, Kantarjian H (eds) Cancer treatment and research: molecular genetics and therapy of leukemia. Kluwer, Boston, pp 261-277
14. Pagliaro LC, Perrotte P, Wood M, Wilson D, Dinney CPN (1998) Safety and distribution of in vivo adenovirus-p53 (Adp53) after intravesical administration (meeting abstract). J Urol 159[Suppl]: A1064
15. Pagliaro LC, Keyhani A, Liu B, Perrotte P, Wood M, Dinney C, Wilson D (1999) p53 adenovirus-mediated gene therapy for human bladder cancer (meeting abstract). Cancer Gene Ther 5 [Suppl 6]: A69
16. Shipley WU, Winter KA, Kaufman DS, Lee WR, Heney NM, Tester WR, Donnelly BJ, Venner PM, Perez CA, Murray KJ, Doggett RS, True LD (1998) Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03. J Clin Oncol 16: 3576-3583
17. Sugrue MM, Deug SY, Lee SW, Aaronson SA (1997) Wildtype p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sei USA 94: 96489653
18. Swisher SG, Roth JA, Nemunaitis J, Lawrence DD, Kemp BL, Carrasco CH, Connors DG, El-Naggar AK, Fossella F, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Mack M, Merritt JA, Nguyen DM, Nesbitt JC, Perez-Soler R, Pisters KMW, Putnam JB, Richli WR, Savin M, Schrump DS, Shin DM, Shulkin A, Walsh GL, Wait J, Weill D, Waugh K A (1999) Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. J Natl Cancer Inst 91: 763-771
19. Takahashi R, Hashimoto T, Xu HJ, Hu SX, Matsui T, Miki T, Bigo-Marshall H, Aaronson SA, Benedict WF (1991) The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sei USA 88: 5257-5261
20. Wood M, Perrotte P, Onishi E, Harper ME, Dinney C, Pagliaro L, Wilson DR (1999) Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse. Cancer Gene Ther 6: 367-372
21. Zhang ZF. Steineck G (1997) Epidemiology and etiology of bladder cancer. In: Raghaven D, Scher HI, Leibel SA, Lange PH (eds) Principles and practice of genitourinary oncology. Lippincott-Raven, Philadelphia, pp 215-222
22. Zhang WW, Fang X, Mazur W, French BA, Georges RN, Roth JA (1994) High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Cancer Gene Ther 1: 5-13
23. Zweibel JA, Nagler C, Smiley JK, Cheson BD (1998) Clinical trials of adenovirus-p53 gene therapy. Oncology 12: 11731175